129 related articles for article (PubMed ID: 9396402)
1. Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease.
Meistrich ML; Wilson G; Mathur K; Fuller LM; Rodriguez MA; McLaughlin P; Romaguera JE; Cabanillas FF; Ha CS; Lipshultz LI; Hagemeister FB
J Clin Oncol; 1997 Dec; 15(12):3488-95. PubMed ID: 9396402
[TBL] [Abstract][Full Text] [Related]
2. Recovery of sperm production following radiation therapy for Hodgkin's disease after induction chemotherapy with mitoxantrone, vincristine, vinblastine, and prednisone (NOVP).
Dubey P; Wilson G; Mathur KK; Hagemeister FB; Fuller LM; Ha CS; Cox JD; Meistrich ML
Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):609-17. PubMed ID: 10701740
[TBL] [Abstract][Full Text] [Related]
3. NOVP: a novel chemotherapeutic regimen with minimal toxicity for treatment of Hodgkin's disease.
Hagemeister FB; Cabanillas F; Velásquez WS; Meistrich ML; Liang JC; McLaughlin P; Redman JR; Romaguera JE; Rodríguez MA; Swan F
Semin Oncol; 1990 Dec; 17(6 Suppl 10):34-8; discussion 38-40. PubMed ID: 2259922
[TBL] [Abstract][Full Text] [Related]
4. Treatment of stage I and II Hodgkin's disease with NOVP (mitoxantrone, vincristine, vinblastine, prednisone) and radiotherapy.
Tormo M; Terol MJ; Marugán I; Solano C; Benet I; Garcia-Conde J
Leuk Lymphoma; 1999 Jun; 34(1-2):137-42. PubMed ID: 10350341
[TBL] [Abstract][Full Text] [Related]
5. NOVP chemotherapy for Hodgkin's disease transiently induces sperm aneuploidies associated with the major clinical aneuploidy syndromes involving chromosomes X, Y, 18, and 21.
Frias S; Van Hummelen P; Meistrich ML; Lowe XR; Hagemeister FB; Shelby MD; Bishop JB; Wyrobek AJ
Cancer Res; 2003 Jan; 63(1):44-51. PubMed ID: 12517776
[TBL] [Abstract][Full Text] [Related]
6. NOVP and radiotherapy for early-staged Hodgkin's disease: an interim analysis.
Hagemeister FB; Fuller L; McLaughlin P; Rodriguez M; Romaguera J; Swan F; Cabanillas F
Ann Oncol; 1992 Sep; 3 Suppl 4():87-90. PubMed ID: 1450086
[TBL] [Abstract][Full Text] [Related]
7. Impact of lymphoma treatments on spermatogenesis and sperm deoxyribonucleic acid: a multicenter prospective study from the CECOS network.
Bujan L; Walschaerts M; Brugnon F; Daudin M; Berthaut I; Auger J; Saias J; Szerman E; Moinard N; Rives N; Hennebicq S
Fertil Steril; 2014 Sep; 102(3):667-674.e3. PubMed ID: 25044088
[TBL] [Abstract][Full Text] [Related]
8. A new chemotherapy regimen for treatment of Hodgkin's disease associated with minimal genotoxicity.
Liang JC; Bailey NM; Gabriel GJ; Kattan MW; Wang RY; Hagemeister FB; Cabanillas FF; Fuller LM
Leuk Lymphoma; 1993 Apr; 9(6):503-8. PubMed ID: 7687918
[TBL] [Abstract][Full Text] [Related]
9. Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy.
da Cunha MF; Meistrich ML; Fuller LM; Cundiff JH; Hagemeister FB; Velasquez WS; McLaughlin P; Riggs SA; Cabanillas FF; Salvador PG
J Clin Oncol; 1984 Jun; 2(6):571-7. PubMed ID: 6547167
[TBL] [Abstract][Full Text] [Related]
10. Meiotic susceptibility for induction of sperm with chromosomal aberrations in patients receiving combination chemotherapy for Hodgkin lymphoma.
Frias S; Van Hummelen P; Meistrich ML; Wyrobek AJ
PLoS One; 2020; 15(12):e0242218. PubMed ID: 33370316
[TBL] [Abstract][Full Text] [Related]
11. Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy.
Hagemeister FB; Purugganan R; Fuller L; McLaughlin P; Swan F; Romaguera J; Rodriguez M; Cabanillas F
Semin Hematol; 1994 Apr; 31(2 Suppl 3):36-43. PubMed ID: 8073308
[No Abstract] [Full Text] [Related]
12. The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapy.
Hagemeister FB; Purugganan R; Podoloff DA; Hess M; Rodriguez MA; McLaughlin P; Swan F; Romaguera JE; Cabanillas F
Ann Oncol; 1994; 5 Suppl 2():59-63. PubMed ID: 8204521
[TBL] [Abstract][Full Text] [Related]
13. Male reproductive potential after MOPP therapy for Hodgkin's disease: a long-term survey.
Marmor D; Duyck F
Andrologia; 1995; 27(2):99-106. PubMed ID: 7598233
[TBL] [Abstract][Full Text] [Related]
14. Are alkylating agents a necessary component in the therapy of Hodgkin's disease.
Hagemeister FB
Leuk Lymphoma; 1993; 10 Suppl():91-7. PubMed ID: 7683230
[TBL] [Abstract][Full Text] [Related]
15. Male infertility caused by the chemotherapy of Hodgkin's disease: MOPP versus ABVD.
Ragni G; Lombardi C; Santoro A; Bestetti O; Wyssling H
Acta Eur Fertil; 1983; 14(3):221-2. PubMed ID: 6199937
[No Abstract] [Full Text] [Related]
16. Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report.
Bartlett NL; Rosenberg SA; Hoppe RT; Hancock SL; Horning SJ
J Clin Oncol; 1995 May; 13(5):1080-8. PubMed ID: 7537796
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
Fermé C; Eghbali H; Meerwaldt JH; Rieux C; Bosq J; Berger F; Girinsky T; Brice P; van't Veer MB; Walewski JA; Lederlin P; Tirelli U; Carde P; Van den Neste E; Gyan E; Monconduit M; Diviné M; Raemaekers JM; Salles G; Noordijk EM; Creemers GJ; Gabarre J; Hagenbeek A; Reman O; Blanc M; Thomas J; Vié B; Kluin-Nelemans JC; Viseu F; Baars JW; Poortmans P; Lugtenburg PJ; Carrie C; Jaubert J; Henry-Amar M;
N Engl J Med; 2007 Nov; 357(19):1916-27. PubMed ID: 17989384
[TBL] [Abstract][Full Text] [Related]
18. Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood.
van Beek RD; Smit M; van den Heuvel-Eibrink MM; de Jong FH; Hakvoort-Cammel FG; van den Bos C; van den Berg H; Weber RF; Pieters R; de Muinck Keizer-Schrama SM
Hum Reprod; 2007 Dec; 22(12):3215-22. PubMed ID: 17981817
[TBL] [Abstract][Full Text] [Related]
19. Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.
Sieber M; Tesch H; Pfistner B; Rueffer U; Lathan B; Brosteanu O; Paulus U; Koch T; Pfreundschuh M; Loeffler M; Engert A; Josting A; Wolf J; Hasenclever D; Franklin J; Duehmke E; Georgii A; Schalk KP; Kirchner H; Doelken G; Munker R; Koch P; Herrmann R; Greil R; Anselmo AP; Diehl V
J Clin Oncol; 2002 Jan; 20(2):476-84. PubMed ID: 11786577
[TBL] [Abstract][Full Text] [Related]
20. Testicular function after combination chemotherapy for Hodgkin's disease.
Asbjornsen G; Molne K; Klepp O; Aakvaag A
Scand J Haematol; 1976 Jan; 16(1):66-9. PubMed ID: 1251141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
